NPPA notifies exemption of Biological E's Pneubevax 14 from DPCO pricing

The National Pharmaceutical Pricing Authority (NPPA) has granted exemption to Biological E's 14-valent pneumococcal conjugate vaccine (PCV), Pneubevax 14 from pricing regulations for a period of five years.

To access the full article, please log in or subscribe.